Biolife Technologies Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 M
- Revenue Growth %
- Profit Growth -220.33%
- Ebitda -742.82%
- Net Worth -12.37%
- Total Assets 52.95%
About Biolife Technologies
Biolife Technologies Private Limited (BTPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2000 and has a history of 24 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Biolife Technologies Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shiven Gaggar and Rishi Gaggar serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2000PTC035011
-
Company No.
035011
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2000
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Biolife Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiven Gaggar
|
Director | 30-Sep-2015 | Current |
|
Rishi Gaggar
|
Director | 30-Sep-2015 | Current |
Financial Performance of Biolife Technologies.
Biolife Technologies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 220.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolife Technologies?
Unlock access to Biolife Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- Andhra Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2003 | Andhra Bank | ₹1.00 M | Satisfied |
How Many Employees Work at Biolife Technologies?
Unlock and access historical data on people associated with Biolife Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolife Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolife Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
